Broadridge Financial Solutions Equity Method Investments increased by 3.3% to $69.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.0%, from $58.50M to $69.60M. Over 4 years (FY 2021 to FY 2025), Equity Method Investments shows an upward trend with a 12.7% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $37.50M | $37.80M | $46.00M | $46.40M | $53.40M | $53.40M | $54.60M | $55.60M | $55.60M | $55.60M | $55.60M | $55.60M | $58.30M | $58.30M | $58.30M | $58.50M | $60.50M | $65.80M | $67.40M | $69.60M |
| QoQ Change | — | +0.8% | +21.7% | +0.9% | +15.1% | +0.0% | +2.2% | +1.8% | +0.0% | +0.0% | +0.0% | +0.0% | +4.9% | +0.0% | +0.0% | +0.3% | +3.4% | +8.8% | +2.4% | +3.3% |
| YoY Change | — | — | — | — | +42.4% | +41.3% | +18.7% | +19.8% | +4.1% | +4.1% | +1.8% | +0.0% | +4.9% | +4.9% | +4.9% | +5.2% | +3.8% | +12.9% | +15.6% | +19.0% |